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Perspectives on this issue of the IJSThis issue starts with a timely review on screen-
ing for cancer by Mr. Jayant Vaidya (see pages
107e112). He points out the beguiling simplicity of
the mantra that underpins the ideology of screen-
ing, ‘‘catch it early and we will save your life’’.
Well, it is not that simple. The problems of lead
time bias, length bias and social class bias explain
why extending survival is not a meaningful end
point in itself. To justify screening you must
demonstrate that, by means of the randomised
control trial, in the population screened there is
a fall in cause specific death and this gain is not
negated by the morbidity of the intervention
itself. Vaidya reaches fair and balanced conclu-
sions whilst not being afraid to express uncertain-
ty. However, space did not allow him to consider
the issues of opportunity costs and the exportation
of appropriate technology.
By opportunity costs we mean the serious consid-
eration of whether the costs of a screening pro-
gramme in cash and manpower might be better
deployed within a health service programme with
strict budget limitation, to save more lives from the
target cancer or other life threatening diseases. This
problem is then amplified when there are attempts
to export the screening technology inappropriately
from rich Western countries to the poor third world
nations who cannot even afford proper sanitation,
never mind MRI scans. Let me illustrate this with two
extreme examples, screening by mammography for
breast cancer and simple inspection of the mouth for
cancers of the oral cavity.
The UK NHS breast screening programme costs
about £50,000,000 ($90,000,000) a year, yet a rea-
sonable estimate of efficacy would suggest that
you have to screen more than 1000 women over 50
years of age for 10 years to save one life.1 Ignoring
ideology this has to be considered a close call. To
further compound the problem a recent paper in1743-9191/$ - see front matter  2005 Surgical Associates Ltd. P
doi:10.1016/j.ijsu.2005.07.006JNCI suggests that the ‘‘effectiveness’’ of screen-
ing, when the programme is rolled out into the
community, is very disappointing and of borderline
significance.2 Therefore in my opinion, to export
this technology to the developing world is utterly
absurd.
At the other extreme a recent paper in the
Lancet concludes that ‘‘oral visual screening can
reduce mortality in high-risk individuals and has
the potential of preventing at least 37,000 oral
cancer deaths worldwide’’3 e now that is what I
call appropriate technology. As if to highlight this
issue, Gukas and Mbah describe the tragic terminal
events of women in Nigeria presenting with grossly
neglected breast cancer (see pages 117e119).
Surely what these disadvantaged societies need
are clinical assistants who go out into the villages
to carry out clinical breast examinations,4 perhaps
at the same time as inspecting the mouth. After all
the pattern of disease in many parts of the third
world resembles that of 18th century London.
This now allows me to highlight the paper by
a medical student Sascha Muldoon, ‘‘Hogarth’s Gin
Lane and Beer Street’’ (see pages 159e162). This
extremely mature essay illustrates the epidemiol-
ogy of common diseases amongst the under-classes
in London 200 years ago and compares this to the
health problems of the drop-outs and ‘druggies’ of
London today. I believe that the study of the history
of art and the history of medicine has much to teach
and inspire our students, I even conduct grand
rounds in the National Gallery in Trafalgar Square
from time to time where much pathology is illus-
trated by fine art. In addition the students’ powers
of observation and deduction can be sharpened
when getting them to try and de-code paintings
such as Holbein’s masterpiece, The Ambassadors.
Talking of Holbein, the Royal College of Sur-
geons of England in Lincoln’s Inn Fields displays hisublished by Elsevier Ltd. All rights reserved.
104 Editorialother masterpiece, which illustrates Henry VIII
presenting the Royal Charter to the company of
Barber Surgeons in about 1530. In those far off
days one graduated as a barber surgeon with the
title magistere or master. Over the years this has
been translated as Mister, which is why surgeons in
the UK are referred to as Mr. rather than Dr. Long
may it remain that way although there are moves
afoot to change this venerable tradition.
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